HOME >> MEDICINE >> NEWS
Yale study shows 25 percent of obese children are at high risk for developing diabetes

New Haven, Conn. Twenty five percent of obese children and 21 percent of obese adolescents tested by Yale researchers were glucose intolerant and at high risk for developing diabetes, according to an article published Thursday in the New England Journal of Medicine.

Sonia Caprio, associate professor of endocrinology and pediatrics at Yale School of Medicine and senior author of the article, said the study was in response to the epidemic of childhood obesity in the United States, along with an accompanying increase in the prevalence of type 2 diabetes among children and adolescents.

Type One diabetes is usually first diagnosed in young children. Type 2, or, adult onset diabetes, often does not manifest itself until a person is middle aged or elderly.

"Most of these children are at high risk for type 2 diabetes," Caprio said. "And, if they develop diabetes before the age of 20, they face a lifetime of being at very high risk for complications from diabetes."

A glucose tolerance test evaluates the bodys capacity to metabolize glucose, based upon the ability of the liver to absorb and store excess glucose as glycogen.

Caprio and her co-researchers looked at a multi-ethnic group of 167 severely obese children and adolescents. All underwent a two-hour oral glucose tolerance test during which glucose, insulin and C-peptide levels were measured.

The glucose intolerance was as prevalent among Caucasians as it was among African American and Hispanic children, who traditionally have higher rates of diabetes. The condition also was more prevalent among girls than boys.

Impaired glucose tolerance was detected in 25 percent of the children four to 10 years of age, and 21 percent of the adolescents 11 to 18 years of age. Silent type 2 diabetes, which means the persons are not aware they are diabetic, was identified in four of the adolescents. Two were Hispanic and two were African American. In addition, three of th
'"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
13-Mar-2002


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. UMaine study looks at infants and chronic nighttime crying
3. Chronic pain treatments more effective when taken together, new study shows
4. UNC study: Most N.C. family practitioners engage in unrecognized community service
5. New study in Nature demonstrates protection against cell death during heart attack
6. UCSF study offers insight into human circadian rhythms
7. International breast cancer prevention study launches in the United States and Canada
8. UW study shows blacks and Latinos are more satisfied with physicians of the same race
9. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
10. Advertising by academic medical centers may risk eroding public trust, says study
11. Fat may promote inflammation, new study suggests

Post Your Comments:
(Date:5/19/2013)... May 19, 2013 The muscles in ... their functionality and one of the biggest and most ... nervous system. The peripheral system comprises of peripheral nerves ... cord. These nerves ensure that the limbs and hands, ... when these nerves get damaged due to trauma or ...
(Date:5/19/2013)... According to a new market research ... – 2018): By Applications (Healthcare (Endoscopy, Radiology, Ophthalmology), ... Contact IS, Infrared, X-Ray) And Geography" published by ... $8.00 billion in 2012 and is expected to ... CAGR of 3.84% from 2013 to 2018. In ...
(Date:5/19/2013)... 2013 The report “Feed Additives Market ... Forecasts up to 2017” published by MarketsandMarkets, defines and ... and forecasting of the global volume and revenue for ... and restraining factors for the global market with analysis ... The market is segmented and revenue is forecasted on ...
(Date:5/19/2013)... May 19, 2013 Americans live closer ... the newest American Veterinary Medical Association (AVMA) U.S. Pet ... dog owners consider their dog a member of the ... said as much five years earlier. , According to ... of the national income dedicated to pets has increased ...
(Date:5/19/2013)... The Fat Loss Code program developed by Shawn ... help people get in shape, and gain a healthy life ... also is a natural fat loss system that provides people ... this fat loss diet program claimed that The Fat Loss ... keep body fat off long-term. After Shawn Stevenson launched this ...
Breaking Medicine News(10 mins):Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2
(Date:5/17/2013)... , May 17, 2013  Atossa Genetics, Inc. (NASDAQ: ... Kyle Guse , Chief Financial Officer & ... MicroCap Conference on Thursday, May 30, 2013, in ... The Company,s presentation is scheduled to begin ... live webcast. To access the webcast, go to www.atossagenetics.com ...
(Date:5/17/2013)... 17, 2013 Oramed Pharmaceuticals Inc. ... drug delivery systems, announced today that the United States ... Investigational New Drug application(IND) for ORMD-0801, its oral insulin ... the FDA clearance to proceed," stated Nadav ... is a major milestone for Oramed and we look ...
(Date:5/17/2013)...  Boston Scientific Corporation (NYSE: BSX ) ... Program May 21-24 in Paris . ... rich and diversified set of data this year at ... global chief medical officer, Boston Scientific.  "The primary endpoint ... NG PROMUS trial, which evaluated our Promus PREMIER ™ ...
Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8
Cached News: